Preclinical efficacy and safety of a novel lentiviral vector for ex vivo gene therapy of p47phox-deficient chronic granulomatous disease.

Molecular Therapy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles